Effects of NFκB decoy oligonucleotides released from biodegradable polymer microparticles on a glioblastoma cell line

Jagjit S. Gill, Xun Zhu, Michael J. Moore, Lichun Lu, Michael J Yaszemski, Anthony John Windebank

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

The objectives of this study were to investigate a nuclear factor-kappa B (NFκB) decoy oligonucleotide (ODN) strategy on the inhibition of glioblastoma (GBM) cell line growth and to evaluate a poly(DL-lactic-co-glycolic acid) (PLGA) microparticle delivery system for the NFκB decoy ODNs in vitro. We have demonstrated that NFκB activation is important in regulating GBM cell line growth. Aberrant nuclear expression of NFκB was found in a panel of GBM cell lines, while untransformed glial cells did not display NFκB activity. Nuclear translocation of NFκB was inhibited by using a "decoy" ODN strategy. NFκB decoy ODNs designed to inhibit NFκB resulted in a significant reduction in cell number (up to 45%) compared to control cultures after 2 days. The reduction in cell number correlated with a decrease in cyclin D1 protein expression and a commensurate decrease in Cdk-4 activity. These results provide evidence suggesting that NFκB mediates cell cycle progression and demonstrates a mechanism linking increased NFκB activity with GBM cell growth and cell cycle disregulation. Decoy ODNs were encapsulated at a yield of 66% in PLGA microparticles and released in a controlled manner in phosphate buffered saline for up to 28 days. Approximately 83% of entrapped ODNs were released by day 28. During 3 days of GBM cell line culture, the released decoy ODNs retained their biologic activity and led to significantly reduced cell number as compared to control cultures. These findings offer a potential therapeutic strategy in the control of human GBM cell line growth in vitro and suggest that PLGA microparticles may be appropriate as delivery vehicles for the "decoy" ODN strategy.

Original languageEnglish (US)
Pages (from-to)2773-2781
Number of pages9
JournalBiomaterials
Volume23
Issue number13
DOIs
StatePublished - 2002

Fingerprint

Biodegradable polymers
NF-kappa B
Oligonucleotides
Glioblastoma
Polymers
Cells
glycolic acid
Cell Line
Acids
Cell Count
Growth
Cell Cycle
Cell growth
Cell culture
Phosphates
Cyclin D1
Chemical activation
Neuroglia
Proteins
Cell Culture Techniques

Keywords

  • Biodegradable microparticles
  • Cell growth
  • Controlled release
  • Glioblastoma (GBM)
  • Nuclear factor-kappa B (NFκB)
  • Phosphorothioated decoy oligonucleotides (ODNS)
  • Poly(DL-lactic-co-glycolic acid) (PLGA)

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Biomedical Engineering

Cite this

Effects of NFκB decoy oligonucleotides released from biodegradable polymer microparticles on a glioblastoma cell line. / Gill, Jagjit S.; Zhu, Xun; Moore, Michael J.; Lu, Lichun; Yaszemski, Michael J; Windebank, Anthony John.

In: Biomaterials, Vol. 23, No. 13, 2002, p. 2773-2781.

Research output: Contribution to journalArticle

@article{5faa65c6467845e0ae37fc939f1a6855,
title = "Effects of NFκB decoy oligonucleotides released from biodegradable polymer microparticles on a glioblastoma cell line",
abstract = "The objectives of this study were to investigate a nuclear factor-kappa B (NFκB) decoy oligonucleotide (ODN) strategy on the inhibition of glioblastoma (GBM) cell line growth and to evaluate a poly(DL-lactic-co-glycolic acid) (PLGA) microparticle delivery system for the NFκB decoy ODNs in vitro. We have demonstrated that NFκB activation is important in regulating GBM cell line growth. Aberrant nuclear expression of NFκB was found in a panel of GBM cell lines, while untransformed glial cells did not display NFκB activity. Nuclear translocation of NFκB was inhibited by using a {"}decoy{"} ODN strategy. NFκB decoy ODNs designed to inhibit NFκB resulted in a significant reduction in cell number (up to 45{\%}) compared to control cultures after 2 days. The reduction in cell number correlated with a decrease in cyclin D1 protein expression and a commensurate decrease in Cdk-4 activity. These results provide evidence suggesting that NFκB mediates cell cycle progression and demonstrates a mechanism linking increased NFκB activity with GBM cell growth and cell cycle disregulation. Decoy ODNs were encapsulated at a yield of 66{\%} in PLGA microparticles and released in a controlled manner in phosphate buffered saline for up to 28 days. Approximately 83{\%} of entrapped ODNs were released by day 28. During 3 days of GBM cell line culture, the released decoy ODNs retained their biologic activity and led to significantly reduced cell number as compared to control cultures. These findings offer a potential therapeutic strategy in the control of human GBM cell line growth in vitro and suggest that PLGA microparticles may be appropriate as delivery vehicles for the {"}decoy{"} ODN strategy.",
keywords = "Biodegradable microparticles, Cell growth, Controlled release, Glioblastoma (GBM), Nuclear factor-kappa B (NFκB), Phosphorothioated decoy oligonucleotides (ODNS), Poly(DL-lactic-co-glycolic acid) (PLGA)",
author = "Gill, {Jagjit S.} and Xun Zhu and Moore, {Michael J.} and Lichun Lu and Yaszemski, {Michael J} and Windebank, {Anthony John}",
year = "2002",
doi = "10.1016/S0142-9612(02)00013-3",
language = "English (US)",
volume = "23",
pages = "2773--2781",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "13",

}

TY - JOUR

T1 - Effects of NFκB decoy oligonucleotides released from biodegradable polymer microparticles on a glioblastoma cell line

AU - Gill, Jagjit S.

AU - Zhu, Xun

AU - Moore, Michael J.

AU - Lu, Lichun

AU - Yaszemski, Michael J

AU - Windebank, Anthony John

PY - 2002

Y1 - 2002

N2 - The objectives of this study were to investigate a nuclear factor-kappa B (NFκB) decoy oligonucleotide (ODN) strategy on the inhibition of glioblastoma (GBM) cell line growth and to evaluate a poly(DL-lactic-co-glycolic acid) (PLGA) microparticle delivery system for the NFκB decoy ODNs in vitro. We have demonstrated that NFκB activation is important in regulating GBM cell line growth. Aberrant nuclear expression of NFκB was found in a panel of GBM cell lines, while untransformed glial cells did not display NFκB activity. Nuclear translocation of NFκB was inhibited by using a "decoy" ODN strategy. NFκB decoy ODNs designed to inhibit NFκB resulted in a significant reduction in cell number (up to 45%) compared to control cultures after 2 days. The reduction in cell number correlated with a decrease in cyclin D1 protein expression and a commensurate decrease in Cdk-4 activity. These results provide evidence suggesting that NFκB mediates cell cycle progression and demonstrates a mechanism linking increased NFκB activity with GBM cell growth and cell cycle disregulation. Decoy ODNs were encapsulated at a yield of 66% in PLGA microparticles and released in a controlled manner in phosphate buffered saline for up to 28 days. Approximately 83% of entrapped ODNs were released by day 28. During 3 days of GBM cell line culture, the released decoy ODNs retained their biologic activity and led to significantly reduced cell number as compared to control cultures. These findings offer a potential therapeutic strategy in the control of human GBM cell line growth in vitro and suggest that PLGA microparticles may be appropriate as delivery vehicles for the "decoy" ODN strategy.

AB - The objectives of this study were to investigate a nuclear factor-kappa B (NFκB) decoy oligonucleotide (ODN) strategy on the inhibition of glioblastoma (GBM) cell line growth and to evaluate a poly(DL-lactic-co-glycolic acid) (PLGA) microparticle delivery system for the NFκB decoy ODNs in vitro. We have demonstrated that NFκB activation is important in regulating GBM cell line growth. Aberrant nuclear expression of NFκB was found in a panel of GBM cell lines, while untransformed glial cells did not display NFκB activity. Nuclear translocation of NFκB was inhibited by using a "decoy" ODN strategy. NFκB decoy ODNs designed to inhibit NFκB resulted in a significant reduction in cell number (up to 45%) compared to control cultures after 2 days. The reduction in cell number correlated with a decrease in cyclin D1 protein expression and a commensurate decrease in Cdk-4 activity. These results provide evidence suggesting that NFκB mediates cell cycle progression and demonstrates a mechanism linking increased NFκB activity with GBM cell growth and cell cycle disregulation. Decoy ODNs were encapsulated at a yield of 66% in PLGA microparticles and released in a controlled manner in phosphate buffered saline for up to 28 days. Approximately 83% of entrapped ODNs were released by day 28. During 3 days of GBM cell line culture, the released decoy ODNs retained their biologic activity and led to significantly reduced cell number as compared to control cultures. These findings offer a potential therapeutic strategy in the control of human GBM cell line growth in vitro and suggest that PLGA microparticles may be appropriate as delivery vehicles for the "decoy" ODN strategy.

KW - Biodegradable microparticles

KW - Cell growth

KW - Controlled release

KW - Glioblastoma (GBM)

KW - Nuclear factor-kappa B (NFκB)

KW - Phosphorothioated decoy oligonucleotides (ODNS)

KW - Poly(DL-lactic-co-glycolic acid) (PLGA)

UR - http://www.scopus.com/inward/record.url?scp=0036011294&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036011294&partnerID=8YFLogxK

U2 - 10.1016/S0142-9612(02)00013-3

DO - 10.1016/S0142-9612(02)00013-3

M3 - Article

C2 - 12059028

AN - SCOPUS:0036011294

VL - 23

SP - 2773

EP - 2781

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 13

ER -